Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study
Outcomes in older patients with Hodgkin lymphoma (HL) are compromised by the interplay of patient frailty and disease aggressiveness; however, current stratification tools, including the International Prognostic Score (IPS) and Comprehensive Geriatric Assessment (CGA), lack sufficient prognostic discrimination in the older HL population. We developed and validated a prognostic model integrating metabolic tumor burden and geriatric assessment. In this retrospective study across 14 centers in China between 2006 and 2024, we enrolled 306 patients aged ≥ 60 years with histologically confirmed HL. Patients were randomly partitioned into training (n = 250) and validation (n = 56) cohorts. Among the 306 patients, 98 deaths and 130 progression events were recorded during follow-up. We analyzed 21 candidate variables. The least absolute shrinkage and selection operator (LASSO) analysis and multivariable Cox regression identified five independent predictors for 5-year overall survival (OS): age > 73 years, baseline 18F-FDG PET/CT-derived total lesion glycolysis (TLG) > 200, hemoglobin ≤ 101 g/L, activities of daily living (ADL) dependence, and lymphocyte-depleted classical Hodgkin lymphoma (LDCHL). A weighted Geriatric Risk Score stratified patients into low-, intermediate-, and high-risk groups. In the validation cohort, the Geriatric Risk Score showed higher discriminatory accuracy than the CGA for both OS (C-index, 0.770 [95% CI, 0.674-0.867] vs. 0.671 [0.581-0.762]) and PFS (0.761 [0.668-0.853] vs. 0.635 [0.535-0.735]). Among advanced-stage (Ann Arbor stage III-IV) patients, it also outperformed the IPS-7 and IPS-3. By integrating metabolic tumor burden and geriatric assessment, the Geriatric Risk Score improves risk stratification over existing tools in older patients with HL.
Authors
- Jiesong Wang (ORCID: https://orcid.org/0000-0001-6846-0079)
- Ganggang Wang (ORCID: https://orcid.org/0000-0001-5388-0847)
- Feng Zhu (ORCID: https://orcid.org/0000-0002-9356-2154)
- Yanan Jiang (ORCID: https://orcid.org/0000-0003-4202-3676)
- Yuanlin Xu (ORCID: https://orcid.org/0000-0003-0742-9945)
- Ji Ma (ORCID: https://orcid.org/0000-0001-5724-1743)
- Ou Bai (ORCID: https://orcid.org/0000-0003-4066-9473)
- Peiqi Zhao (ORCID: https://orcid.org/0000-0001-8223-5679)
- Shaozhen Chen (ORCID: https://orcid.org/0000-0001-8420-2707)
- Shu Zhao (ORCID: https://orcid.org/0000-0002-7202-6598)
- Yihan Wang (ORCID: https://orcid.org/0000-0002-1163-4610)
- Qingyuan Zhang (ORCID: https://orcid.org/0000-0001-8116-5293)
- Junqing Xu
- Yajun Li (ORCID: https://orcid.org/0000-0002-8142-5160)
- Lei Zhu (ORCID: https://orcid.org/0000-0003-0213-3619)
- Hui-Lai Zhang (ORCID: https://orcid.org/0000-0002-3919-1655)
- Wei Guo (ORCID: https://orcid.org/0000-0003-1982-7131)
- Jianxia He (ORCID: https://orcid.org/0000-0003-0138-0570)
- Li Li (ORCID: https://orcid.org/0000-0003-1802-9517)
- Shukai Qiao
- Chen Huang
- Min Bai
- Wenyue Yu
- Hui Zhou
- Yanyan Zhang (ORCID: https://orcid.org/0009-0009-9897-0534)
- Liping Su
Institutions
- Qingdao University (CN)
- Hebei Medical University (CN)
- University of Science and Technology of China (CN)
- Fujian Medical University (CN)
- Central South University (CN)
- Harbin Medical University (CN)
- Xuzhou Medical College (CN)
- Jilin University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Yuhuangding Hospital (CN)
- Second Hospital of Hebei Medical University (CN)
- Shanxi Provincial Cancer Hospital (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Hunan Cancer Hospital (CN)
- First Hospital of Jilin University (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
- Henan Cancer Hospital (CN)
- Shanxi Academy of Medical Sciences (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- American Journal of Hematology
- Published
- 2026-08-13
- DOI
- https://doi.org/10.1002/ajh.70456
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00